JP Morgan Chase
HCCC

JP Morgan Chase’s Healthcare Capital Corp. Class A common stock HCCC Stock Holding History

JP Morgan Chase’s Portfolio HCCC Stock Details HCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-425,500
Closed -$4.2M – 7292
2021
Q4 		$4.2M Sell
425,500
-127,099
-23% -$1.26M ﹤0.01% 3215
2021
Q3 		$5.45M Buy
+552,599
New +$5.42M ﹤0.01% 2963

JP Morgan Chase's HCCC Position: Q1 2022 in Review

JP Morgan Chase sold out of Healthcare Capital Corp. Class A common stock (HCCC) in Q1 2022, closing a stake of 425,500 shares — an estimated $4.2M sold.

JP Morgan Chase first reported a position in HCCC in Q3 2021 and held it in 2 quarters. The position peaked at $5.45M in Q3 2021. 0 funds tracked by Wall St. Rank hold HCCC as of Q1 2022.

  • JP Morgan Chase reported no remaining Healthcare Capital Corp. Class A common stock position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Chase sold 425,500 Healthcare Capital Corp. Class A common stock shares in Q1 2022, an estimated $4.2M.
  • JP Morgan Chase first reported a position in Healthcare Capital Corp. Class A common stock in Q3 2021 and held it in 2 quarters.
  • JP Morgan Chase's Healthcare Capital Corp. Class A common stock position peaked at $5.45M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Healthcare Capital Corp. Class A common stock as of Q1 2022.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.